en ENGLISH
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
3/2020
vol. 95
 
Poleć ten artykuł:
Udostępnij:
Opis przypadku

Severe acute respiratory syndrome coronavirus 2 and influenza A virus co-infection in a nine-year-old boy from a family cluster – case report

Anna Tomasik
1, 2
,
Maria Pokorska-Śpiewak
1, 3
,
Ewa Talarek
1, 3
,
Magdalena Marczyńska
1, 3

  1. Regional Hospital of Infectious Diseases in Warsaw, Warsaw, Poland
  2. Doctoral School, Medical University of Warsaw, Warsaw, Poland
  3. Department of Children’s Infectious Diseases, Medical University of Warsaw, Warsaw, Poland
Pediatr Pol 2020; 95 (3): 175–177
Data publikacji online: 2020/10/30
Plik artykułu:
Pobierz cytowanie
 
Metryki PlumX:
 
1. World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (access: 26 May 2020).
2. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Published 2020. https://coronavirus.jhu.edu/ map.html (access: 24 April 2020).
3. Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145: e20200702.
4. Rasmussen SA, Thompson LA. Coronavirus Disease 2019 and Children. What Pediatric Health Care Clinicians Need to Know. JAMA Pediatr 2020; 174: 743-744.
5. Zimmermann P, Curtis N. Coronavirus Infection in Children Including COVID-19, an overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J 2020; 39: 355-368.
6. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review, EClinicalMedicine 2020; 24: 100433.
7. McCreary E, Pogue J. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infect Dis 2020; 7: ofaa105.
8. Tan EL, Ooi EE, Lin CY, et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004; 10: 581-586.
9. Bacharier LB, TW Guilbert TW, Mauger DT, et al. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: A randomized clinical trial. JAMA 2015; 314: 2034-2044.
10. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56: 105949.
11. Wehl G, Laible M, Rauchenzauner M. Co-infection of SARS CoV2 and influenza A in a Pediatric Patient in Germany. Klin Padiatr 2020; 232: 217-218.
12. Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis 2020; 26: 1324-1326.
13. Wu D, Lu J, Ma X, et al. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Pediatr Infect Dis J 2020; 39: e79.
Copyright: © 2020 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.